<乌鸦传媒>Should Doctors Worry About 'Nuremberg 2.0?' It's a "completely misleading application of the concepts of the Nuremberg trials" May 19, 2022
<乌鸦传媒>FDA Rejects Cheap Antidepressant to Treat Early COVID David Boulware, who submitted the EUA for fluvoxamine, argues the agency is "behind the times" May 17, 2022
<乌鸦传媒>First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetes Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
<乌鸦传媒>More Support Needed to Shore Up Nurse Pipeline, Experts Say There have to be more nurses in health system governance "at the highest levels" May 11, 2022
<乌鸦传媒>New York Doc Tries to Take Down No Surprises Act But lawsuit to overturn the law is "really, really weak," legal expert says May 10, 2022
<乌鸦传媒>Restrictions on Mifepristone a Barrier to Miscarriage Care, Surveys Show Over a third of respondents do not prescribe the drug for early pregnancy loss, despite efficacy May 10, 2022
<乌鸦传媒>PBMs Under Fire at Senate Hearing Expert witnesses call for strong consumer protection, federal regulation May 05, 2022
<乌鸦传媒>Early Alzheimer's Test Gets FDA Nod First in vitro diagnostic to detect amyloid in early disease setting May 05, 2022
<乌鸦传媒>Dem Senator Introduces Bill to Stem Attacks on Healthcare Workers Measure calls for workplaces to "adopt proven prevention techniques" May 04, 2022
<乌鸦传媒>Two New Regimens Win FDA Approval for H. Pylori Infection Dual and triple vonoprazan-based treatments offer physicians another set of options May 04, 2022
<乌鸦传媒>Columbia University Finally Scrubs Relationship With Dr. Oz But it took the institution "far too long," according to one critic May 04, 2022
<乌鸦传媒>How Far Should the Menthol Ban Go? It's time to ban menthol in cigarettes -- but not necessarily in all tobacco products May 02, 2022
<乌鸦传媒>FDA OKs New Nonstimulant Option for Adult ADHD New selective norepinephrine reuptake inhibitor is no longer just for kids May 02, 2022
<乌鸦传媒>FDA Proposes Ban on Menthol Cigarettes "Long-awaited action" should reduce youth smoking, health disparities Apr 28, 2022
<乌鸦传媒>FDA Approves First Drug for Recurrent Yeast Infections Vivjoa indicated for infertile or postmenopausal women Apr 28, 2022
<乌鸦传媒>Biden Administration Beefs Up Access to COVID Antiviral Pills Secures 20 million courses of Paxlovid, plans to offer antiviral at up to 20,000 more pharmacies Apr 26, 2022
<乌鸦传媒>Hospitals Turn to Signing Bonuses to Lure Nurses, Survey Says A fourth of hospital leaders said they expect 100 or more nurse position openings in 2022 Apr 21, 2022
<乌鸦传媒>Biden Administration Working to Rescind Trump-Era 'Conscience Clause' Rule Regulation would have enforced health workers' rights to decline participation in some procedures Apr 20, 2022
<乌鸦传媒>Rash of Heart Attacks After Biden-Trump Election Do major political events factor into cardiovascular risk? Apr 20, 2022
<乌鸦传媒>FDA Issues Warning on Prenatal Genetic Tests Relying on results could lead to inappropriate medical decisions, agency warns Apr 19, 2022
<乌鸦传媒>Everybody Loves CHIP, So Why Isn't It Permanently Funded? It has more to do with political will and finding the right way to achieve it, analyst says Apr 15, 2022
<乌鸦传媒>Healthcare Consolidation Expected to Continue, Expert Says Small-scale players will merge with others, especially in the second half of 2022, she predicts Apr 14, 2022
<乌鸦传媒>Medicare Finalizes Limits on Aducanumab Coverage But decision allows flexibility for some anti-amyloid Alzheimer's drugs Apr 08, 2022
<乌鸦传媒>Changes Needed in How We Address Mental Health, Says U.S. Policy Advisor Susan Rice outlines three goals in Biden administration's plan to address mental health crisis Apr 07, 2022
<乌鸦传媒>$150K Prostate Cancer Drug Draws New Attention to 'March-In' Rights Advocates want Biden administration to enable Xtandi generics; industry warns against it Apr 06, 2022
<乌鸦传媒>White House Rolls Out National Plan to Fight Long COVID New initiative aims to better understand, prevent, detect, and treat the condition Apr 05, 2022
<乌鸦传媒>First Topical Therapy for Facial Angiofibroma Nabs FDA Approval New alternative to dermabrasion, laser treatment, surgery Apr 04, 2022
<乌鸦传媒>HHS Claws Back $100 Million in Provider Pandemic Relief Money Providers who did not comply with agency's reporting requirements forced to pay back pandemic aid Apr 01, 2022
<乌鸦传媒>CDC Reports Warn of Teen 'Mental Health Crisis' During Pandemic In survey, over one-third of high school students reported poor mental health Mar 31, 2022
<乌鸦传媒>ALS Drug Needs More Evidence, FDA Advisors Say But vote was close and panelists remain hopeful about AMX0035 Mar 31, 2022
<乌鸦传媒>Make Naloxone More Accessible to At-Risk Americans, Experts Say Allow OTC sale, reimburse pharmacists, and support harm-reduction groups, they urged Mar 30, 2022
<乌鸦传媒>House Members Remain Divided on Universal Healthcare Republicans, Democrats differ on potential costs and effects of Medicare for All Mar 29, 2022
<乌鸦传媒>Another Oral Testosterone Undecanoate OK'd for Hypogonadism FDA approval of Tlando follows in the footsteps of Jatenzo Mar 29, 2022
<乌鸦传媒>Permanent Daylight Saving Time Is the Wrong Choice The Sunshine Protection Act will cause circadian misalignment with serious health consequences Mar 28, 2022
<乌鸦传媒>Novel Fixed-Dose Immunotherapy Combo Wins FDA Approval Nivolumab plus relatlimab doubled progression-free survival in unresectable melanoma Mar 21, 2022
<乌鸦传媒>Military Exposure to Burn Pits Under Scrutiny Wearable technology, better registries, "compassionate common sense" urged over denials of harm Mar 17, 2022
<乌鸦传媒>Medicare Claws Back Money for Dubious Birth-Tissue Stem Cell Shots Government seeks to recoup more than 2 years of payments for unproven treatments Mar 16, 2022
<乌鸦传媒>Meet the Primary Care Doc Who Wants the World to Go Back to Normal Lucy McBride, MD, has become a loud, controversial voice in the debate on COVID precautions Mar 15, 2022
<乌鸦传媒>No Medicare Payment Hike Needed for Docs in 2023, MedPAC Says Beneficiaries seem to have adequate access to care, and few physicians are dropping out Mar 15, 2022
<乌鸦传媒>First Generic OK'd for Popular Asthma, COPD Inhaler FDA approves Mylan's Symbicort copy, reflecting agency's commitment to "increase competition" Mar 15, 2022
